135 related articles for article (PubMed ID: 36609831)
41. Human papillomavirus type 8 E6 oncoprotein inhibits transcription of the PDZ protein syntenin-2.
Lazić D; Hufbauer M; Zigrino P; Buchholz S; Kazem S; Feltkamp MC; Mauch C; Steger G; Pfister H; Akgül B
J Virol; 2012 Aug; 86(15):7943-52. PubMed ID: 22623796
[TBL] [Abstract][Full Text] [Related]
42. Roles of the PDZ-binding motif of HPV 16 E6 protein in oncogenic transformation of human cervical keratinocytes.
Yoshimatsu Y; Nakahara T; Tanaka K; Inagawa Y; Narisawa-Saito M; Yugawa T; Ohno SI; Fujita M; Nakagama H; Kiyono T
Cancer Sci; 2017 Jul; 108(7):1303-1309. PubMed ID: 28440909
[TBL] [Abstract][Full Text] [Related]
43. Molecular insights into the interaction of HPV-16 E6 variants against MAGI-1 PDZ1 domain.
Araujo-Arcos LE; Montaño S; Bello-Rios C; Garibay-Cerdenares OL; Leyva-Vázquez MA; Illades-Aguiar B
Sci Rep; 2022 Feb; 12(1):1898. PubMed ID: 35115618
[TBL] [Abstract][Full Text] [Related]
44. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase.
Nakagawa S; Huibregtse JM
Mol Cell Biol; 2000 Nov; 20(21):8244-53. PubMed ID: 11027293
[TBL] [Abstract][Full Text] [Related]
45. A conserved C-terminal sequence of high-risk cutaneous beta-human papillomavirus E6 proteins alters localization and signalling of β1-integrin to promote cell migration.
Holloway A; Storey A
J Gen Virol; 2014 Jan; 95(Pt 1):123-134. PubMed ID: 24154967
[TBL] [Abstract][Full Text] [Related]
46. A systematic analysis of human papillomavirus (HPV) E6 PDZ substrates identifies MAGI-1 as a major target of HPV type 16 (HPV-16) and HPV-18 whose loss accompanies disruption of tight junctions.
Kranjec C; Banks L
J Virol; 2011 Feb; 85(4):1757-64. PubMed ID: 21123374
[TBL] [Abstract][Full Text] [Related]
47. HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background.
Massimi P; Shai A; Lambert P; Banks L
Oncogene; 2008 Mar; 27(12):1800-4. PubMed ID: 17934525
[TBL] [Abstract][Full Text] [Related]
48. Activation of cap-dependent translation by mucosal human papillomavirus E6 proteins is dependent on the integrity of the LXXLL binding motif.
Spangle JM; Ghosh-Choudhury N; Munger K
J Virol; 2012 Jul; 86(14):7466-72. PubMed ID: 22553330
[TBL] [Abstract][Full Text] [Related]
49. HPV E6 and E7 oncoproteins cooperatively alter the expression of Disc Large 1 polarity protein in epithelial cells.
Dizanzo MP; Marziali F; Brunet Avalos C; Bugnon Valdano M; Leiva S; Cavatorta AL; Gardiol D
BMC Cancer; 2020 Apr; 20(1):293. PubMed ID: 32264889
[TBL] [Abstract][Full Text] [Related]
50. A Drosophila Model of HPV E6-Induced Malignancy Reveals Essential Roles for Magi and the Insulin Receptor.
Padash Barmchi M; Gilbert M; Thomas M; Banks L; Zhang B; Auld VJ
PLoS Pathog; 2016 Aug; 12(8):e1005789. PubMed ID: 27537218
[TBL] [Abstract][Full Text] [Related]
51. Stabilization of HPV16 E6 protein by PDZ proteins, and potential implications for genome maintenance.
Nicolaides L; Davy C; Raj K; Kranjec C; Banks L; Doorbar J
Virology; 2011 Jun; 414(2):137-45. PubMed ID: 21489588
[TBL] [Abstract][Full Text] [Related]
52. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.
Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H
Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343
[TBL] [Abstract][Full Text] [Related]
53. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J
Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542
[TBL] [Abstract][Full Text] [Related]
54. Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators.
Tomaić V; Gardiol D; Massimi P; Ozbun M; Myers M; Banks L
Oncogene; 2009 Jan; 28(1):1-8. PubMed ID: 18820705
[TBL] [Abstract][Full Text] [Related]
55. Solution structure of the hDlg/SAP97 PDZ2 domain and its mechanism of interaction with HPV-18 papillomavirus E6 protein.
Liu Y; Henry GD; Hegde RS; Baleja JD
Biochemistry; 2007 Sep; 46(38):10864-74. PubMed ID: 17713926
[TBL] [Abstract][Full Text] [Related]
56. The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo.
Nguyen ML; Nguyen MM; Lee D; Griep AE; Lambert PF
J Virol; 2003 Jun; 77(12):6957-64. PubMed ID: 12768014
[TBL] [Abstract][Full Text] [Related]
57. Design of a PDZbody, a bivalent binder of the E6 protein from human papillomavirus.
Karlsson OA; Ramirez J; Öberg D; Malmqvist T; Engström Å; Friberg M; Chi CN; Widersten M; Travé G; Nilsson MT; Jemth P
Sci Rep; 2015 Mar; 5():9382. PubMed ID: 25797137
[TBL] [Abstract][Full Text] [Related]
58. Molecular dissection of the E6 PBM identifies essential residues regulating Chk1 phosphorylation and subsequent 14-3-3 recognition.
Vats A; Thatte JV; Banks L
Tumour Virus Res; 2023 Jun; 15():200257. PubMed ID: 36775199
[TBL] [Abstract][Full Text] [Related]
59. The structural and dynamic response of MAGI-1 PDZ1 with noncanonical domain boundaries to the binding of human papillomavirus E6.
Charbonnier S; Nominé Y; Ramírez J; Luck K; Chapelle A; Stote RH; Travé G; Kieffer B; Atkinson RA
J Mol Biol; 2011 Mar; 406(5):745-63. PubMed ID: 21238461
[TBL] [Abstract][Full Text] [Related]
60. Comprehensive analysis of host cellular interactions with human papillomavirus E6 proteins identifies new E6 binding partners and reflects viral diversity.
White EA; Kramer RE; Tan MJ; Hayes SD; Harper JW; Howley PM
J Virol; 2012 Dec; 86(24):13174-86. PubMed ID: 23015706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]